⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Journal of Inflammation ResearchOpen Access

The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma

Ling Duan Wenhui Guo Shuo Yin Shoubo Yang Jie Liu Yunyun Duan Gehong Dong Wenbin Li Feng Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the prognostic significance of pan-immune-inflammation value (PIV) and PILE score (based on PIV, lactate dehydrogenase (LDH), and Eastern Cooperative Oncology Group Performance Status (ECOG PS)) in patients with primary central nervous system lymphoma (PCNSL).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Duan et al. (2024) studied this question.

synapsesocial.com/papers/68e5e1dbb6db643587576ac1 https://doi.org/10.2147/jir.s468537

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The candidate novel markers PIV and PILE score to predict survival outcomes and therapeutic response in patients with primary central nervous system lymphoma.2024 · 1 citations
2Prognostic application regarding PILE score and the pan-immune-inflammation value in diffuse large B-Cell LymphomaOriginal Research · 2026
3The prognostic impact of the pan-immune-inflammation value (PIV) on the efficacy of treatment and clinical outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC)2024
4The Construction of a Nomogram Using the Pan-Immune-Inflammation Value Combined with a PILE Score for Immunotherapy Prediction Prognosis in Advanced NSCLC2024 · 2 citations
5Pan-Immune-Inflammation Value: A Novel Marker for Chemotherapy Response in Locally Advanced Breast Cancer2025 · 1 citations

More related papers

Pan-Immune-Inflammation Value and Bone Marrow Infiltration in Lymphoma: A Retrospective Cohort Analysis2025
Prognostic value of pan-immune-inflammation in breast cancer patients with lymph node metastasis and neoadjuvant therapy2025
Prospective evaluation of the pan-immune-inflammation value (PIV) as an independent prognostic biomarker in EGFR-mutated advanced non-small cell lung cancer.2026

More from Journal of Inflammation Research

Macrophage Immunometabolism in Epicardial Adipose Tissue and Obesity-Related Atrial FibrillationTue,
The Gut Microbiota–NLRP3 Inflammasome Axis in Chronic Heart Failure: Mechanisms Across Heart Failure Phenotypes and Therapeutic PerspectivesTue,